NuVasive NuvaLine Mobile App— 510(k) K162647

Name: FDA 510(k) clearance K162647
Creator: U.S. Food and Drug Administration
Published: 2017-05-01

Substantially Equivalent

Nu Vasive, Incorporated

FDA 510(k) clearance K162647 for NuVasive NuvaLine Mobile App, Substantially Equivalent on 2017-05-01. Applicant: Nu Vasive, Incorporated. Device class: 2.

Clearance details

Applicant: Nu Vasive, Incorporated
Product code: Code LLZ
Device class: Class 2
Regulation: 21 CFR 892.2050
Advisory panel: Radiology
Date received: 2016-09-22
Decision date: 2017-05-01
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Diego, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LLZ

view all

More clearances from Nu Vasive, Incorporated

view all

K231735 — NuVasive CoRoent Small Interbody System +5 more2023-07-11
K230894 — NuVasive Modulus ALIF System2023-06-16
K230989 — Rod Registration Frame2023-05-05
K223181 — NuVasive Reline System2023-01-11
K221751 — NuVasive Cohere ALIF System Intervertebral Body Fusion Device2022-10-21

Adverse events under product code LLZ

product code LLZ

Death: 13
Total: 13

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.